Anthony C. Faber
0000-0002-7246-4272
Publication & Citation Trends
Publications
0 total
E2 displacement of CIP2A from TOPBP1 activates the DNA damage response during papillomavirus life cycles
Cited by 3
Semantic Scholar
A Critical Appraisal of the Utility of Targeting Therapy-induced Senescence for Cancer Treatment.
Cited by 11
Semantic Scholar
Targeting SUMOylation promotes cBAF complex stabilization and disruption of the SS18::SSX transcriptome in synovial sarcoma
Cited by 2
Semantic Scholar
Abstract 1381: BCL-2 selective inhibitor venetoclax combined with topoisomerase I inhibitor irinotecan is effective in small cell lung cancer (SCLC)
Cited by 0
Semantic Scholar
Abstract 2728: Lysine acetyltransferase inhibitor MG149 reduces tumor recurrence in triple-negative breast cancer
Cited by 0
Semantic Scholar
Androgen deprivation-induced senescence confers sensitivity to a senolytic strategy in prostate cancer.
Cited by 6
Semantic Scholar
Abstract 7071: Pharmacological targeting of SUMOylation leads to cBAF complex stabilization and disruption of the synovial sarcoma signature
Cited by 0
Semantic Scholar
Targeting of SUMOylation leads to cBAF complex stabilization and disruption of the SS18::SSX transcriptome in Synovial Sarcoma OA
Cited by 3
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(51)
RNA modifications and cancer
(40)
Neuroblastoma Research and Treatments
(38)
PARP inhibition in cancer therapy
(27)
Lung Cancer Research Studies
(27)
Affiliations
Boston College
Tufts Medical Center
Harvard University
University of Richmond
Virginia Commonwealth University